The grey market for peptides has exploded in the last 10 years, pushed by raising curiosity in therapeutic peptides, tightening restrictions on compounded drugs, and the simple economics of supply and desire. The explosion of fascination in GLP-one agonists like semaglutide and tirzepatide has made monumental grey market demand from https://annek392fbr2.blogdosaga.com/profile